Mouse HLA-DR Monoclonal Antibody | anti-HLA-DR antibody

Anti-HLA-DR Pacific Orange

• Reactivity: Dog, Non-human primates, Human
• Applications: Flow Cytometry, Functional Assay
• Purity: The purified antibody is conjugated with Pacific Orange under optimum conditions. The conjugate is purified by size-exclusion chromatography.
• Synonyms: HLA-DR; Monoclonal Antibody; Anti-HLA-DR Pacific Orange; anti-HLA-DR antibody

• Host: Mouse
• Reactivity: Dog, Non-human primates, Human
• Clonality: Monoclonal
• Isotype: Mouse IgG2a kappa
• Clone Number: L243
• Specificity: The mouse monoclonal antibody L243 recognizes specifically an extracellular epitope on HLA-DR molecules, both peptide-loaded and empty.
• Purity/Purification: The purified antibody is conjugated with Pacific Orange under optimum conditions. The conjugate is purified by size-exclusion chromatography.
• Form/Format: Pacific Orange. Stabilizing phosphate buffered saline (PBS) solution containing 15mM sodium azide

• Applicable Applications for anti-HLA-DR antibody: Flow Cytometry (FC/FACS) (QC tested)
• Application Notes: FC/FACS: The reagent is designed for analysis of human blood cells using 4ul reagent/100ul of whole blood or 10⁶ cells in a suspension. The content of a vial (0.4 ml) is sufficient for 100 tests.
• Immunogen: Human B lymphocytes
• Preparation and Storage: Store in the dark at 2-8 degree C. Do not freeze. Avoid prolonged exposure to light. Do not use after expiration date stamped on vial label.

Flow Cytometry (FC/FACS)

(Flow cytometry analysis (surface staining) of HLA-DR in human peripheral blood with anti-HLA-DR (L243) Pacific Orange™.)

Related Product Information for anti-HLA-DR antibody

HLA-DR, a member of MHC class II glycoproteins, that bind intracellularly processed peptides and present them to the Th cells, is composed of 36kDa alpha chain and 27kDa beta chain, both anchored in the plasma membrane. Together with other MHC II molecules HLA-DR plays a central role in the immune system.

References

*Coral S, Pucillo C, Leonardi A, Fonsatti E, Altomonte M, Maio M: Triggering of HLA-DR antigens differentially modulates tumor necrosis factor alpha release by B cells at distinct stage of maturation. Cell Growth Differ. 1997 May;8(5):581-8., URL: http://www.ncbi.nlm.nih.gov/pubmed/9149909,*Muczynski KA, Ekle DM, Coder DM, Anderson SK: Normal human kidney HLA-DR-expressing renal microvascular endothelial cells: characterization, isolation, and regulation of MHC class II expression. J Am Soc Nephrol. 2003 May;14(5):1336-48., URL: http://www.ncbi.nlm.nih.gov/pubmed/12707403,*Cantin R, Martin G, Tremblay MJ: A novel virus capture assay reveals a differential acquisition of host HLA-DR by clinical isolates of human immunodeficiency virus type 1 expanded in primary human cells depending on the nature of producing cells and the donor source. J Gen Virol. 2001 Dec;82(Pt 12):2979-87., URL: http://www.ncbi.nlm.nih.gov/pubmed/11714974,*Swiatek-de Lange M, Rist W, Stahl HF, Weith A, Lenter MC: Comment on "MHC class II expression identifies Functional Application (FUNC)tionally distinct human regulatory T cells". J Immunol. 2008 Mar 15;180(6):3625; author reply 3626., URL: http://www.ncbi.nlm.nih.gov/pubmedterm=comment%20,*De Gassart A, Camosseto V, Thibodeau J, Ceppi M, Catalan N, Pierre P, Gatti E: MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation. Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3491-6., URL: http://www.ncbi.nlm.nih.gov/pubmedterm=gassart%20,*Ivanov A, Beers SA, Walshe CA, Honeychurch J, Alduaij W, Cox KL, Potter KN, Murray S, Chan CH, Klymenko T, Erenpreisa J, Glennie MJ, Illidge TM, Cragg MS: Monoclonal antibodies directed to CD20 and HLA-DR can elicit homotypic adhesion followed by lysosome-mediated cell death in human lymphoma and leukemia cells. J Clin Invest. 2009 Aug;119(8):2143-59., URL: http://www.ncbi.nlm.nih.gov/pubmed/19620786,*Kalka-Moll WM, Tzianabos AO, Bryant PW, Niemeyer M, Ploegh HL, Kasper DL: Zwitterionic polysaccharides stimulate T cells by MHC class II-dependent interactions. J Immunol. 2002 Dec 1;169(11):6149-53., URL: http://www.ncbi.nlm.nih.gov/pubmed/term=tzianabos,*Bouillon M, El Fakhry Y, Girouard J, Khalil H, Thibodeau J, Mourad W: Lipid raft-dependent and -independent signaling through HLA-DR molecules. J Biol Chem. 2003 Feb 28;278(9):7099-107., URL: http://www.ncbi.nlm.nih.gov/pubmed/12499388